Living Cell Technologies Ltd (LCT):企業のM&A・提携動向(医療機器分野)

◆英語タイトル:Living Cell Technologies Ltd (LCT) - Medical Equipment - Deals and Alliances Profile
◆商品コード:GDME61193D
◆発行会社(調査会社):GlobalData
◆発行日:2017年1月24日
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥27,500見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD500 ⇒換算¥55,000見積依頼/購入/質問フォーム
Enterprisewide License(複数国内共有可)USD750 ⇒換算¥82,500見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000を加算
※納期:即日~2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
【レポートの概要】

Summary
Living Cell Technologies Ltd (LCT) is a biotechnology company that develops cell-based therapeutics for the treatment of neurological diseases, diabetes, and stroke and hearing loss. It focuses on discovering regenerative treatments which restore function using naturally occurring cells. LCT develops its candidates based on its proprietary encapsulation technology, Immupel. Its lead product candidate, NTCELL is an alginate coated capsule containing clusters of neonatal porcine choroid plexus cells. It is in Phase IIb clinical trials for the treatment of Parkinson’s disease. The company is also developing the candidate in a number of other central nervous system indications, including Huntington’s, Alzheimer’s and motor neurone diseases including amyotrophic lateral sclerosis (ALS). LCT’s joint venture, Diatranz Otsuka Limited develops Diabecell, a cell therapy for type 1 diabetes. LCT is headquartered in Auckland, the New Zealand.

Living Cell Technologies Ltd (LCT) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Living Cell Technologies Ltd, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Living Cell Technologies Ltd, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Living Cell Technologies Ltd, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Living Cell Technologies Ltd, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Living Cell Technologies Ltd, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Living Cell Technologies Ltd, Medical Equipment, Deal Details 10
Equity Offering 10
Living Cell Technologies to Raise Funds through Share Purchase Plan 10
Living Cell Technologies Raises USD2 Million in Private Placement of Shares 10
Living Cell Technologies Completes Private Placement Of US$1.71 Million 12
Living Cell Technologies Completes Private Placement Of Shares For US$3.2 Million 13
Acquisition 14
Jiangsu Aosaikang Pharma Acquires Living Cell Technologies 14
Living Cell Technologies Ltd – Key Competitors 16
Key Employees 17
Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Recent Developments 19
Financial Announcements 19
Feb 26, 2016: Half yearly report ended 31 December 2015 : Living Cell Technologies 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
Living Cell Technologies Ltd, Medical Equipment, Key Facts, 2016 1
Living Cell Technologies Ltd, Medical Equipment, Deals Summary, 2011 to YTD 2017 1
Living Cell Technologies Ltd, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Living Cell Technologies Ltd, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Living Cell Technologies Ltd, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Living Cell Technologies Ltd, Deals By Market, 2011 to YTD 2017 8
Living Cell Technologies Ltd, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Living Cell Technologies to Raise Funds through Share Purchase Plan 10
Living Cell Technologies Raises USD2 Million in Private Placement of Shares 10
Living Cell Technologies Completes Private Placement Of US$1.71 Million 12
Living Cell Technologies Completes Private Placement Of Shares For US$3.2 Million 13
Jiangsu Aosaikang Pharma Acquires Living Cell Technologies 14
Living Cell Technologies Ltd, Key Competitors 16
Living Cell Technologies Ltd, Key Employees 17
Living Cell Technologies Ltd, Subsidiaries 18

List of Figures
Living Cell Technologies Ltd, Medical Equipment, Deals by Type, 2011 to YTD 2017 1
Living Cell Technologies Ltd, Medical Equipment, Deals By Year, 2011 to YTD 2017 1
Living Cell Technologies Ltd, Medical Equipment, Deals By Region, 2011 to YTD 2017 1
Living Cell Technologies Ltd, Medical Equipment, Deals By Market, 2011 to YTD 2017 1
Living Cell Technologies Ltd, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Living Cell Technologies Ltd, Medical Equipment, Deals by Type, 2011 to YTD 2017 6
Living Cell Technologies Ltd, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Living Cell Technologies Ltd, Medical Equipment, Deals by Market, 2011 to YTD 2017 8

★調査レポート[Living Cell Technologies Ltd (LCT):企業のM&A・提携動向(医療機器分野)] (コード:GDME61193D)販売に関する免責事項を必ずご確認ください。
★調査レポート[Living Cell Technologies Ltd (LCT):企業のM&A・提携動向(医療機器分野)]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆